Skip to main content
/
Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
127.85
-0.05 (-0.04%)
At close: Jun 6, 2025, 4:00 PM
127.76
-0.09 (-0.07%)
After-hours: Jun 6, 2025, 7:02 PM EDT

Blueprint Medicines Revenue by Segment

Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product
535.84M478.95M405.86M331.90M257.66M204.21M163.24M137.64M
Product Growth
107.96%134.54%148.63%141.13%104.14%83.98%61.69%53.63%
Collaboration License and Other
-29.87M-30.89M24.55M45.17M52.97M60.47M
Collaboration License and Other Growth
--33.87%--48.91%-51.75%-31.08%-63.17%-57.08%

Revenue by Geography

Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
468.15M421.84M361.35M297.33M230.18M181.97M144.52M120.45M
United States Growth
103.38%131.82%150.04%146.85%107.70%87.16%--
Rest of World
67.69M57.11M44.51M34.57M27.48M22.24M18.72M17.19M
Rest of World Growth
146.30%156.85%137.78%101.06%78.51%61.52%--
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.